berk-neurobiologyandtherapeutic-2019.pdf (1.59 MB)
Neurobiology and therapeutic potential of cyclooxygenase-2 (COX-2) inhibitors for inflammation in neuropsychiatric disorders
journal contribution
posted on 2019-09-01, 00:00 authored by Rickinder Sethi, Nieves Gomez-Coronado, Adam WalkerAdam Walker, Oliver D'Arcy Robertson, B Agustini, Michael BerkMichael Berk, Seetal DoddSeetal DoddNeurobiology and therapeutic potential of cyclooxygenase-2 (COX-2) inhibitors for inflammation in neuropsychiatric disorders
History
Journal
Frontiers in psychiatryVolume
10Article number
605Pagination
1 - 21Publisher
Frontiers MediaLocation
Lausanne, SwitzerlandPublisher DOI
Link to full text
ISSN
1664-0640Language
engPublication classification
C1 Refereed article in a scholarly journalCopyright notice
2019, Sethi, Gómez-Coronado, Walker, Robertson, Agustini, Berk and Dodd.Usage metrics
Categories
No categories selectedKeywords
Science & TechnologyLife Sciences & BiomedicinePsychiatrydepressionbipolar disorderschizophreniaobsessive compulsive disorderautism spectrum disorderinflammationcyclooxygenase-2 inhibitorsC-REACTIVE PROTEINMAJOR DEPRESSIVE DISORDEROBSESSIVE-COMPULSIVE DISORDERRANDOMIZED DOUBLE-BLINDTO-MODERATE DEPRESSIONAUTISM SPECTRUM DISORDERSNECROSIS-FACTOR-ALPHAADJUNCTIVE CELECOXIB TREATMENTSCHIZOPHRENIA CLINICAL STATUSINTERFERON-INDUCED DEPRESSION
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC